Users Online: 424

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

  Article Access Statistics

Year : 2022 | Volume:  12 | Issue Number:  3 | Page:  99-104

REVIEW ARTICLE

The Risk of COVID-19 in Patients of Chronic Kidney Disease with Cognitive Dysfunction Like Alzheimer Disease: A Perspective on Erythropoietin as a Potential Adjuvant Therapy
Ganesan Vinothkumar, Nehru Mohanraj, Shankar Geethamalini, Prabhu Venkataraman

Number of times this article was viewed 618
Number of times this article has been printed  from the site 36
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal